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A B S T R A C T
Fast progress of the next generation sequencing (NGS) technology has allowed global transcriptional proﬁling
and genome-wide mapping of transcription factor binding sites in various cellular contexts. However, limited
number of replicates and high amount of data processing may weaken the signiﬁcance of the ﬁndings.
Comparative analyses of independent data sets acquired in the diﬀerent laboratories would greatly increase the
validity of the data. Runx2 is the key transcription factor regulating osteoblast diﬀerentiation and bone
formation. We performed a comparative analysis of three published Runx2 data sets of chromatin immunopre-
cipitation followed by deep sequencing (ChIP-seq) analysis in osteoblasts from mouse and human origin.
Moreover, we assessed the similarity of the corresponding transcription data of these studies available online.
The ChIP-seq data analysis conﬁrmed general features of Runx2 binding, including location at genic vs
intergenic regions and abundant Runx2 binding on promoters of the highly expressed genes. We also found high
frequency of Runx2 DNA binding without a consensus Runx2 motif at the binding site. Importantly, mouse and
human Runx2 showed moderately similar binding patterns in terms of peak-associated closest genes and their
associated genomic ontology (GO) pathways. Accordingly, the gene expression proﬁles were highly similar and
osteoblastic phenotype was prominent in the diﬀerentiated stage in both species. In conclusion, ChIP-seq method
shows good reproducibility in the context of mature osteoblasts, and mouse and human osteoblast models
resemble each other closely in Runx2 binding and in gene expression proﬁles, supporting the use of these models
as adequate tools in studying osteoblast diﬀerentiation.
1. Introduction
Fast development and easy availability of high throughput sequen-
cing technologies has allowed rapid accumulation of unbiased genome
wide transcription data of several cell and tissue types. Use of
chromatin immunoprecipitation combined to NGS sequencing (ChIP-
seq) in turn has resulted in rapidly accumulating research literature on
global transcription factor (TF) binding site mapping of many diﬀerent
cell types (Cao et al., 2010; Handoko et al., 2011; Heinz and Glass,
2012; Lin et al., 2010; Mikkelsen et al., 2010). Despite the fast progress
in the ﬁeld, there has been relatively few studies utilizing ChIP-seq in
cells of the osteogenic lineage, reﬂecting perhaps the challenging
sample material mature bone matrix producing osteoblasts represent.
Nevertheless, ChIP-seq analyses of Runx2 (Håkelien et al., 2014; Meyer
et al., 2014b; Wu et al., 2014), C/EBPβ (Meyer et al., 2014b), VDR and
RXR (Meyer et al., 2014a) in osteoblasts have recently been reported.
Because of the high amount of data NGS-approaches produce, it is
evident that there are several putative candidate genes and mechanisms
to be followed by future studies, eventually generating vast amounts of
new information on the regulation of osteoblastogenesis. However, the
choice of signiﬁcant candidates to take forward is challenging as the
statistical power remains usually low because generally only few
replicate samples are included in the individual experiments. Thus
the more studies are published and compared to previous data by
bioinformatic tools and approaches, the more consistent and reliable
information concerning individual genes and pathways can emerge.
Osteoblasts originate from mesenchymal stem cells (MSC) that can
give rise to a number of specialized cell types such as adipocytes,
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myoblasts and chondrocytes. Numerous hormones, growth factors and
cytokines regulate the diﬀerentiation of an MSC to a speciﬁc cell type,
driven by a series of transcription factors that control phenotype-
speciﬁc gene expression. In case of osteoblasts, early bipotent chondro-
osteogenic progenitor cells express transcription factor SOX9, which is
then followed by the expression of Runt family transcription factor
(Runx2) and its downstream target Osterix (Osx) in preosteoblasts
(Long, 2012). Runx2 and Osx are both indispensable for osteoblast
diﬀerentiation as their null mutant mice show total absence of bone and
osteoblasts (Ducy, 2000; Nakashima et al., 2002).
Runx2 belongs to Runt family of transcription factors (Runx1–3)
that regulate development and diﬀerentiation of many diﬀerent cell
lineages. Runx2 protein contains a conserved 128 amino acid Runt
domain, which is responsible for the DNA binding and heterodimeriza-
tion with CBFβ, that enhances Runx2 binding to DNA (reviewed in
Cohen, 2009). Importantly, Runx2 can interact with several proteins
including co-regulatory proteins and chromatin remodeling factors,
leading to complex role in regulating bone speciﬁc genes and diﬀer-
entiation. Control of Runx2 expression is complex, and includes
epigenetic mechanisms such as miRNAs and several histone modifying
enzymes (Huang et al., 2009; Rojas et al., 2015; Yang et al., 2013).
Moreover, Runx2 activity is regulated by several posttranslational
modiﬁcations such as phosphorylation, acetylation, ubiquitination
(reviewed in Jonason et al., 2009) and sumoylation (Kim et al., 2014).
Mouse MC3T3-E1 cell line is a clonal non-transformed cell line
established from new born mouse calvaria (Sudo et al., 1983) and is
commonly used for studying osteoblast diﬀerentiation in vitro. These
cells represent Runx2 positive pre-osteoblasts committed to osteogenic
lineage. MC3T3-E1 cells maturate to mineralizing osteoblasts in the
presence of standard osteogenic medium containing ascorbic acid and
Na-β-glycerophosphate. Of human origin, there are few non-trans-
formed osteoblast cell lines. Thus diﬀerentiation of human cells is often
investigated by using primary human osteoblasts, immortalized human
osteoblast lines (HOBs) or immortalized mesenchymal stem cells
(iMSCs). Critical evaluation of the current osteoblast cell culture models
is important for further development of reliable and adequate in vitro
models, not only for high standard basic research but also for use in
pharmaceutical and biomaterial research. Typically, phenotypic assess-
ment of osteoblastic cells include measurement of the expression level
of osteoblastic genes (Runx2, Sp7, Ocn, Opn), alkaline phosphatase
(ALP) activity and formation of mineralized bone matrix in diﬀerentia-
tion cultures. Comparison of diﬀerent models has often been limited to
these few phenotypic properties.
Intriguingly, three papers were published reporting ChIP-seq ana-
lyses of genome-wide Runx2 binding in the context of osteoblast
diﬀerentiation in spring 2014. Two of them, papers from the labora-
tories of Wesley Pike (Meyer et al., 2014b) and Jane Lian (Wu et al.,
2014), described Runx2 ChIP-seq analyses of mouse MC3T3-E1 in
undiﬀerentiated and diﬀerentiated state. Paper of Håkelien and co-
workers in turn (Håkelien et al., 2014), described mapping of Runx2
binding sites in iMSCs (Skarn et al., 2014) diﬀerentiated to mature
osteoblasts in vitro. In general, there was high degree of similarity in
the results reported in these papers, but due to the publishing dates
close to each other, the data sets were not directly compared by any of
the authors. Our approach was to objectively evaluate and compare the
published global gene transcription and Runx2 ChIP-seq data sets
collected from these three selected osteoblast studies. Our speciﬁc aims
were 1) to study diﬀerences in the Runx2 genomic occupancy in mouse
MC3T3-E1 osteoblasts during their diﬀerentiation in data sets produced
by two diﬀerent laboratories, to evaluate the reproducibility of ChIP-
seq experiments in this model, 2) to examine the interspecies diﬀer-
ences in Runx2 binding patterns and target genes between human and
mouse samples and 3) to evaluate the similarity of gene expression
proﬁles of undiﬀerentiated and diﬀerentiated osteoblasts from mouse
and human origin.
2. Methods
2.1. Original data
Summary of the published Runx2 ChIP-seq data and gene expression
data used in the study are described in Table I.
2.1.1. Data pre-processing and alignment
Raw ChIP-seq sequencing reads were downloaded from European
Nucleotide Archive (ENA) and the reads were subjected to quality
control using FastQC software (Andrews, 2010). Alignments to refer-
ence genomes were performed using bowtie2 (version 2.1.0)
(Langmead and Salzberg, 2012), with reads from Meyer et al. and Wu
et al. samples aligned to mouse mm9 genome assembly and reads from
Håkelien et al. samples aligned to human hg19 genome assembly. All
samples were subjected to PCR duplicated removal, after which FastQC
quality control was applied again. Alignment statistics of the Bowtie2
alignments are shown in Supplemental Table I. Obtained alignments
were inspected visually using Integrative Genomics Viewer (IGV)
(Robinson et al., 2011).
2.1.2. ChIP-seq peak detection and annotation
Peaks were detected from the alignment ﬁles by MACS 1.4.2
software (Zhang et al., 2008) using default settings. For Håkelien
et al. sample, the peak enrichment was determined relative to a control
ChIP with anti-H3 antibody in day 28 iMSC3 cells. For Meyer et al.
samples, the peak enrichments were determined relative to a control
with IgG antibody in day 0 and day 15 cells. For Wu et al. samples, the
peak enrichment was determined relative to sonicated input DNA from
day 9 MC3T3-E1 cells. Peaks with p-value< 10−10 were used in all
downstream analyses.
Peaks were annotated to the closest protein coding genes using
Bedtools closest (Quinlan and Hall, 2010) tool and gene annotations of
the peaks lists sorted by ascending p-value were compared. Because of
Table I
Summary of the experiments and data provided by the original articles.
Study Cell model ChIP-seq
time points
Gene expression data:
method, time points
ENA study number
Håkelien et al.:
The Regulatory Landscape of Osteogenic Diﬀerentiation
iMSC#3
Immortalized human
mesenchymal stem cell line
28 d RNA-seq,
0 d cells
28 d cells
ERP003787
Meyer et al.:
The RUNX2 Cistrome in Osteoblasts: characterization, down-
regulation following diﬀerentiation, and relationship to gene
expression
MC3T3-E1
Mouse preosteoblastic cell line
0 d
15 d
Microarray (Mouse 385 K
microarray, Roche Nimblegen)
0 d cells (POB)
15 d cells (OB)
SRP016885
Wu et al.:
Genomic Occupancy of Runx2 with Global Expression Proﬁling
Identiﬁes a Novel Dimension to Control of Osteoblastogenesis
MC3T3-E1
Mouse preosteoblastic cell line,
subclone 4
0 d
9 d
28 d
Microarray (GeneChip Mouse Gene
1.0 ST Array rev.4, Aﬀymetrix)
ShRunx2 (9d) cells
ShScr (0 d and 9 d) cells
SRP035343
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higher deviation of Meyer et al. 15d samples, the replicate with highest
FRiP (Fraction of Reads in Peaks) scores and largest amount of high
conﬁdence peaks were used for comparisons with other samples. For
cross-species sample comparison, human gene symbols were translated
to orthologous mouse gene symbols. For mouse samples from Meyer
et al. and Wu et al. experiments, the overlap of the MACS detected peak
regions was also compared directly using R package ChIPSeeker (Yu
et al., 2015), which calculated statistical signiﬁcance of the peak
overlap.
The genomic locations of Runx2 binding peaks were examined using
a peak annotation function of HOMER (Hypergeometric Optimization
of Motif EnRichment) software (Heinz et al., 2010). Similar analysis
was also performed using Genomic Regions Enrichment of Annotations
Tool (GREAT) (McLean et al., 2010). The analysis was done using
default settings that assign a basal regulatory domain of −5 kb and
+1 kb of the transcriptional start site (TSS) and extend it in both
directions to the nearest gene's basal regulatory domain but no> 1000
kb distance. The ChIP-seq peak regions were then associated with the
genes in whose regulatory domains they laid. GREAT was also used to
ﬁnd GO annotations that are enriched among the genes near the ChIP-
seq peak regions. For GO enrichment analysis, the assigned gene
regulatory domain extended in both directions to the midpoint between
the gene's TSS and the nearest gene's TSS but no> 50 kb distance.
2.1.3. Runx2 binding motif scan
Enrichment analysis of conserved Runx2 binding sequence motifs
was performed using HOMER software (Heinz et al., 2010). The
analysis was done using default settings and repeat-masked sequence.
2.2. DNA microarray data analysis
2.2.1. Processing of Meyer et al. microarray data
Meyer et al. provided gene expression data obtained from mouse
385 k microarrays (Roche NimbleGen) of pre-osteoblast stage MC3T3-
E1 cells (POB) and osteoblast stage MC3T3-E1 cells (OB) after 15 days
of diﬀerentiation. The data consisted of normalized gene expression
values with and without log2 transformation as well as log2 fold-
change values and was used in this analysis as provided. For some genes
there were more than one fold change value in the table provided by
Meyer et al., which were apparently obtained from multiple probes
detecting the same gene. These values were averaged by taking a
geometric mean of the fold change and the resulting single fold change
value for each gene was log2-transformed.
2.2.2. Processing of Wu et al. microarray data
Wu et al. provided gene expression data obtained from GeneChip
Mouse Gene 1.0 ST Array rev.4 (Aﬀymetrix) as RMA normalized values
in the Gene Expression Omnibus (GEO) database (accession number
GSE53982). The normalized, log2-transformed gene expression values
were used for further analyses. The samples used for this analysis were
day 0 MC3T3-E1 cells infected with control Scramble-shRNA and the
same cells after 9 days of diﬀerentiation. Diﬀerential expression
between the day 0 and day 9 Scr-shRNA cells was determined using
R Bioconductor package limma (Ritchie et al., 2015) with obtained p-
values adjusted for multiple testing by Benjamini-Hochberg method
(Benjamini and Hochberg, 1995). Diﬀerential expression was deﬁned as
signiﬁcant if the adjusted p-value was below the signiﬁcance level 0.05
and absolute log2 fold change was at least 1.
2.2.3. Processing of Håkelien et al. RNA-seq data
For Håkelien et al. study, raw RNA-seq read ﬁles of day 0
undiﬀerentiated iMSC3 cells and day 28 diﬀerentiated iMSC3 cells
(two replicates of each) were downloaded from European Nucleotide
Archive (ENA) (accession number ERA246830). Quality control of the
reads was performed using FastQC software. The quality of all read ﬁles
was found to be reasonable and no pre-processing was considered
necessary. The reads were aligned against human hg19 genome using
Bowtie2. Bedtools multicov tool (Quinlan and Hall, 2010) was used for
counting the reads aligned to all exonic regions in the genome. The
counts from all exons belonging to the same gene were then summar-
ized to get gene-level read counts, and the obtained counts were FPKM
(Fragments Per Kilobase of exon per Million fragments mapped)
normalized. The non-normalized read counts were used for diﬀerential
expression analysis by R Bioconductor package DESeq2 (version 1.6.3)
(Love et al., 2014). The obtained p-values were adjusted for multiple
testing by Benjamini-Hochberg method. Diﬀerential expression was
deﬁned as signiﬁcant if the adjusted p-value was below the signiﬁcance
level 0.05 and absolute log2 fold change was at least 1.
2.3. Gene expression data comparison
For comparison of the gene expression proﬁles from Meyer et al.,
Wu et al. and Håkelien et al. studies, the gene symbols in Håkelien et al.
data were mapped to orthologous mouse gene symbols. Log2-trans-
formed expression values of all samples, scaled to the same range, were
hierarchically clustered based on computed Euclidian distance of the
samples with complete linkage method.
Further comparison of the gene expression proﬁles between the
three studies utilizing diﬀerent platforms and two diﬀerent species was
done using R Bioconductor package OrderedList (Yang et al., 2006)
with function that detects similarities between two ordered gene lists.
The function compares two-ranked list, in this case gene lists ordered by
decreasing gene expression value, and a similarity score is assigned
based on the number of overlapping genes in the top ranks. Random
scores are computed by comparing one list to the randomly shuﬄed
second list, and based on the random scores an empirical p-value can be
computed for the observed score. 5000 permutations were used here for
estimating the empirical p-values.
Pathway enrichment analyses for the three gene expression data sets
were performed by GSEAPreranked, which runs Gene Set Enrichment
Analysis (GSEA) (Subramanian et al., 2005) against a user-supplied,
ranked list of genes. For the analysis, the gene expression lists of all
samples containing all the genes were ordered based on the log2
expression values in descending order and mouse gene symbols in
Meyer and Wu gene lists were mapped to orthologous human gene
symbols. Enrichment was tested for all available KEGG pathway gene
sets with number of permutations set to 1000 and enrichment statistic
set as classic. For comparison of the pathway enrichment results, the
results were ﬁltered using a stringent false discovery rate (FDR) cutoﬀ
of 0.01 and ordered by ascending FDR.
2.4. Comparison of gene expression to Runx2 occupancy at gene promoters
The relationship between Runx2 binding to gene promoter regions
and gene expression was studied using the undiﬀerentiated and
diﬀerentiated mouse samples from Meyer and Wu studies. Gene
expression lists ordered by descending log2 expression values were
subset into four groups: (1) Genes with expression level within the
highest 20% in undiﬀerentiated cells, (2) genes with expression level
within the lowest 20% in undiﬀerentiated cells, (3) genes with
expression level within the highest 20% in diﬀerentiated cells and (4)
genes with expression level within the lowest 20% in diﬀerentiated
cells. The number of Runx2 ChIP-seq peaks on gene promoter areas in
samples at diﬀerent time points (days 0 and 15 from Meyer study and
days 0, 9 and 28 from Wu study) were analyzed and the peak
distributions between the four gene groups were compared.
3. Results and discussion
3.1. General comparison of the experimental set up between the studies
The experimental setup for osteoblast diﬀerentiation culture was
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highly similar in all three Runx2 ChIP-seq studies analyzed here, with
some variation in the model cell line, in the length of the culture and
composition of the osteogenic medium (Table I). In the two MC3T3-E1
studies, diﬀerent clones of MC3T3-E1 cells were used, Wu et al. using a
later isolated rapidly mineralizing subclone from the original MC3T3-
E1 cells (Wang et al., 1999). iMSC#3 line used in Håkelien et al. study
was produced by immortalizing human bone marrow derived stromal
cells by retroviral transduction of telomerase reverse transcriptase
(TERT). These cells can diﬀerentiate to osteoblasts and adipocytes
(Skarn et al., 2014). Osteogenic medium contained ascorbic acid and
Na-β-glycerophosphate in all studies, but dexamethasone was used only
in the cultures of iMSCs. Osteoblast maturation was veriﬁed similarly in
all studies by standard methods of ALP, alizarin red and Von Kossa
staining to demonstrate lineage commitment and bone nodule forma-
tion, respectively.
For Runx2 ChIP-seq, in both MC3T3-E1 studies the ﬁrst cell stage
chosen for analysis were the undiﬀerentiated conﬂuent cells, and the
endpoint for sample collection was either 15d (Meyer et al.) or 28d (Wu
et al.) after diﬀerentiation induction. In addition, Wu et al. included a
timepoint representing matrix-producing cells prior to mineralization
(9d). In iMSCs, only the 28d diﬀerentiated mature osteoblasts were
analyzed for Runx2 binding. Two diﬀerent Runx2 antibodies were used
in the studies discussed here, a rabbit polyclonal antibody for MC3T3-
E1 cells, and a mouse monoclonal antibody for iMSCs. Notably, the
epitope for both these antibodies is in the very same region of Runx2
protein. Despite standardized protocols for some cell types, chromatin
immunoprecipitation (ChIP) is a challenging method requiring exten-
sive optimization of sample and antibody-speciﬁc conditions including
e.g. crosslinking time and temperature, cell lysis, chromatin shearing
and washing conditions. Furthermore, special requirements concerning
input DNA size and quality have to be met in order to produce good
quality sequencing libraries for ChIP-seq. The late-stage osteoblastic
cells are tightly surrounded by the collagenous matrix and thus are
diﬃcult sample material for ChIP. In the studies discussed here, there
was some variability in the ChIP procedures including e.g. cell lysis and
sonication conditions, which might have an impact on the sample
quality and results, but these aspects are not in the focus in our study.
The method and experimental set up for transcriptional proﬁling of
osteoblastic cells as well as approaches to correlate Runx2 binding site
data to transcriptome diﬀered between the studies. Meyer et al.
performed microarray expression analysis of MC3T3-E1 at undiﬀeren-
tiated and diﬀerentiated state while Håkelien et al. used RNA-seq
analysis of iMSC#3 cells of undiﬀerentiated and 28d diﬀerentiated
cells. Wu et al. in turn did a microarray gene expression proﬁling of 9d
diﬀerentiated MC3T3-E1 cells with shRNA mediated knockdown of
Runx2, and compared the changes in gene expression to control shRNA
cells. In order to compare gene expression proﬁles between the studies,
only the control scrambled shRNA data of Wu et al. study was analyzed
here, corresponding to the parental MC3T3-E1 cells of Meyer et al.
study.
3.2. ChIP-seq analysis
3.2.1. Quality of the sequencing data
Raw ChIP-seq sequencing reads were downloaded from ENA and
subjected to quality control. In summary, Wu et al. and Håkelien et al.
samples showed very high quality throughout the reads. Meyer et al.
samples had noticeable decrease in quality towards the end of reads,
especially in 15d replicate sample 1, but as the majority of bases in
reads were of very good quality and the median quality scores were
within the very good quality range, no further pre-processing was
considered necessary.
3.2.2. Comparison of peak detection results
After duplicate removal the aligned reads were used for peak
detection using MACS (Model-Based Analysis of ChIP-seq) (Zhang
et al., 2008). Peak detection results for all samples are shown in
Table II. In summary, large amounts of Runx2 peaks were detected in
all samples even if more stringent p-value cutoﬀ of 10−10 was used.
Noticeable is the reduction in peak count in Meyer day 15 replicate 1
sample after more stringent cutoﬀ was applied, in accordance with the
lower quality of reads that was observed in quality control. A simple
quality metrics FrIP for ChIP-seq data is also shown in Table II. The
recommendation for this metrics is≥1% by ENCODE consortium for a
successful experiment (Landt et al., 2012), and the scores of all samples
exceed this limit. Peaks with p-value< 10−10 were used in all down-
stream analyses.
In the published paper Meyer et al. reported contraction of the
Runx2 cistrome during diﬀerentiation, demonstrated by 12,674 and
6272 genomic regions with Runx2 binding in the early and late state
osteoblasts, respectively (Meyer et al., 2014b). Wu et al. in turn
reported approximately 25,000 signiﬁcantly enriched regions at day 0
and an increase in the number of Runx2 bound sites in later timepoints,
yielding up to 80,000 Runx2 enriched regions in MC3T3-E1 cells (Wu
et al., 2014). In the re-analysis performed here, we did not observe as
high variation in the detected peak numbers between the two MC3T3-
E1 studies as reported previously, suggesting the diﬀerence in the peak
numbers between the original studies to be related to the data analysis
rather than to a major diﬀerence in Runx2 binding abundance (Table
II). In our analysis, Wu et al. samples showed increased number of
Runx2 peaks in D9 and D28 samples compared to D0 sample, whereas
peak number in Meyer et al. study stayed constant between the
timepoints (when excluding the one D15 replicate of lower quality)
(Table II). In the original papers, there was a minor diﬀerence in Runx2
protein expression pattern, the protein level being constant in Meyer's
paper but showing increase in Wu's paper, which is in accordance with
the dynamics in Runx2 peak numbers observed. In iMSC#3 cells, we
found large number of Runx2 peaks (80061) and very high FRiP value
(48,7%), suggesting a successful ChIP experiment. However, Håkelien
et al. reported only 9549 peaks in the 50 kb region of closest 5′ gene
end, suggesting major diﬀerences in the analysis methods and/or
ﬁltering parameters used. Thus, we will not further compare our iMSC
analysis results to the published results, but use our de novo analysis
results to the analysis of mouse MC3T3-E1 cells in order to perform
inter-species comparisons.
3.2.3. Comparison of annotated genes close to Runx2 peaks
Peaks were annotated to the closest protein coding genes using
bedtools closest tool (Quinlan and Hall, 2010). Annotated peak lists
were sorted by ascending p-value so that the most enriched peaks of
Table II
ChIP-seq peak detection results.
Meyer et al. Wu et al. Håkelien et al.
MACS detection D0_1 D0_2 D15_1 D15_2 D0 D9 D28 D28
Peak count
Cut oﬀ p < 10–5 38,211 34,296 46,249 34,296 23,667 96,368 49,425 122,325
Cut oﬀ p < 10–10 26,297 22,966 9810 22,966 14,396 53,887 32,894 80,061
FRiP (Fraction of Reads in Peaks) 17.3% 13.6% 4.3% 11.3% 4.1% 21.0% 13.0% 48.7%
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each sample could be compared. To allow cross-species comparisons,
the human gene symbols were translated to orthologous mouse gene
symbols. Venn diagrams of the unique and common genes annotated to
the top 5000 most enriched peaks are shown in Fig. 1. Meyer et al. and
Wu et al. undiﬀerentiated mouse samples seem to be fairly similar, with
70% of top 5000 peak annotations shared between the samples
(Fig. 1A), whereas diﬀerentiated samples (Meyer et al. day 15 and
Wu et al. day 28) show a smaller, 59%, overlap (Fig. 1B). Comparison of
Meyer et al. undiﬀerentiated and diﬀerentiated samples shows an
overlap of 74% in annotations, with corresponding comparisons
between Wu samples showing 68% and 71% overlaps for day 9 and
day 28 samples, respectively (Supplementary Fig. 1). In conclusion, the
comparisons between the diﬀerentiation stages suggest that Runx2
constitutively occupies more than half of the total Runx2 bound genes
regardless of the diﬀerentiation stage.
Comparison of peak annotations of human diﬀerentiated iMSC3
samples to diﬀerentiated mouse MC3T3-E1 samples from both Meyer
and Wu shows overlaps of 39% and 43% in top 5000 annotated genes,
respectively (Fig. 1C,D). The overlap percentages are, as could be
expected, lower than those of within-species comparisons and in line
with previous ﬁndings that have shown that most TF binding events are
species-speciﬁc (Wilson and Odom, 2009). However, altogether 1344
genes from top 5000 annotated genes were in common for all samples
in the last diﬀerentiation time point, suggesting substantial similarity in
Runx2 peak associated genes between the species and experiments. This
could suggest that these genes are especially important for the Runx2-
mediated regulation of osteoblast diﬀerentiation.
For Meyer and Wu mouse samples it was possible to compare
directly the overlap of the peak regions. The results indicate that peaks
in undiﬀerentiated and diﬀerentiated mouse samples have a highly
signiﬁcant overlap both within and between the studies (Table III). For
example, when comparing undiﬀerentiated cells to diﬀerentiated cells
in each study, 88% (Wu et al. study) and 67% (Meyer et al. study) of the
peak regions at day 0 were present also in diﬀerentiated cells. More-
over, at day 0, 88% of peaks observed in Wu et al. study are detected
also in Meyer et al. day 0 sample. In the diﬀerentiated cells,
corresponding overlap was 50%, possibly related to the variable time
course and the diﬀerent MC3T3-E1 cell clones used in the two studies as
well as the challenging sample material at the late time points.
Importantly, these results indicate that ChIP-seq experiments in
MC3T3-E1 cells show relatively high reproducibility in two individual
studies and again that majority of the Runx2 bound sites are constant
during diﬀerentiation.
3.2.4. Comparison of genomic locations of Runx2 peaks
The genomic locations of Runx2 binding peaks were examined using
a peak annotation function of HOMER software. The distributions of
Runx2 peaks are displayed in Fig. 2A. In accordance with the original
articles, the vast majority of Runx2 binding occurred at intergenic and
intronic regions. The greatest variation between the diﬀerentiation
stages was in Runx2 occupancy at promoters, with higher occupancy in
Fig. 1. Venn diagrams of peak annotation comparisons. Gene annotations of the top 5000 most enriched Runx2 ChIP-seq peaks were used for comparisons: A–B) Undiﬀerentiated and
diﬀerentiated MC3T3-E1 cells of Meyer et al. and Wu et al. Samples were compared, and C–D) Diﬀerentiated Håkelien et al. iMSC3 cells were compared to Meyer et al. and Wu et al.
diﬀerentiated MC3T3-E1 cells.
Table III
Statistical test of ChIP-seq peak overlap in mouse samples.
Query
sample
Target
sample
Query
peak
count
Target
peak
count
Overlapping
peaks
p-value Adjusted
p-value
Meyer
DO_1
Meyer
D15_2
26,297 34,871 17,569 0 0
Wu D0 Wu D9 14,396 53,887 13,255 0 0
Wu D0 Wu D28 14,396 32,894 12,714 0 0
Meyer
D0_1
Wu D0 26,297 14,396 12,609 0 0
Meyer
D15-
_2
Wu D28 34,871 32,894 16,577 0 0
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Fig. 2. Genome-wide proﬁle of Runx2 occupancy. A–B) Distribution of Runx2 binding peaks across mouse and human genomes were classiﬁed into eight categories: Exon, Intron,
Promoter (−1 kb to +100 bp from transcription start site), TTS region (−100 bp to +1 kb from transcription termination site), 5′ UTR exon, 3′ UTR exon, Intergenic region and other
regions. Peak distributions in all samples are plotted by peak number (A) and by the percentage of total peaks (B). C–E) Analysis of the Runx2 peak association to genomic regions using
GREAT at the last time point in each of the three studies. In the analysis, a basal gene regulatory domain of−5 kb and 1 kb of the TSS was assigned and extended in both directions to the
nearest gene's basal regulatory domain with a maximum distance of 1000 kb. Runx2 peak regions where then associated with the genes in whose regulatory domains they are located. In
addition, GO Biological Process term enrichment analysis of the last time point samples in each study using GREAT is presented (right panels). In this analysis, the assigned gene
regulatory domain extended in both directions to the midpoint between the gene's TSS and the nearest gene's TSS with a maximum distance of 50 kb. The ﬁgure shows the most enriched
GO terms among the genes near the ChIP-seq peak regions.
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undiﬀerentiated cells in both MC3T3-E1 studies (Fig. 2A,B, Table IV).
Similar analysis was performed using GREAT software, which ﬁnds GO
annotations that are enriched among the genes near the ChIP-seq peak
regions. Graphs showing the distance between peak regions and their
putatively regulated genes as well as the most enriched biological
process GO terms obtained from GREAT analysis for diﬀerentiated cells
are shown in Fig. 2C–E. In summary, the pattern of Runx2 peak
enrichment was very similar between the experiments, showing clear
enrichment of Runx2 binding in the vicinity of TSS. Among enriched
GO terms in biological processes category there were both common and
closely related terms and some unique pathways, reﬂecting the overlap
of the annotated genes close to the peaks (Fig. 1). The enriched terms
such as RNA related processes, cell- and tissue morphology related
pathways, resembled closely the published data of each report. The
minor diﬀerences in the term enrichments to the original articles results
might be due to diﬀerences in performing the analysis, for example Wu
et al. used time-dependent dynamic clusters of Runx2 peaks, whereas in
our analysis all Runx2 peaks at certain time point were included.
3.2.5. Runx2 binding motif enrichment in Runx2 peak regions
ChIP-seq peaks were scanned for conserved TF sequence motifs
using HOMER software. HOMER includes a motif database that is
mostly based on the analysis of public ChIP-Seq data sets (Heinz et al.,
2010). The full tables of the results of the motif scan are presented upon
request. In mouse samples, the most signiﬁcantly enriched motifs were
three motifs that have been experimentally associated with binding of
RUNX-family of transcription factors ((A/T/C)TGTGGTT(A/T); (G/T)
(T/C)TGTGGTTT; CTGTGGTTT(G/C))), presented in Table V. These
motifs were present in altogether 36–54% of Runx2 peaks in all MC3T3-
E1 samples (Table VI). In the motif scan, two mismatches to the
consensus sequence were allowed in the analysis, leading to inclusion of
high number of diﬀerent variant motifs as Runx2 motifs, referred
hereafter altogether as Runx2 motif. Accordingly, signiﬁcant enrich-
ment of a classic Runx2 binding core motif TGTGGT at the Runx2-
bound regions was reported in both MC3T3-E1 studies previously. In
iMSCs on the other hand, the known Runx2 motifs were found in only
14,4% of the peaks and the motifs ranked as most signiﬁcantly enriched
were for AP1 and ETS family transcription factors. Thus, in iMSC
sample, although having the highest number of peaks left after quality
ﬁltering, only minority of these peaks appear to contain Runx2 binding
motifs. This may indicate that the Håkelien et al. sample contains more
false positives and would require more stringent ﬁltering of the
detected peaks, or that the Runx2 motif in human DNA is highly
variable and was not recognized in our analysis.
Interestingly, the motif scan revealed also other signiﬁcantly
enriched TF consensus motifs at Runx2 peak regions. Secondary
binding motifs may suggest for example protein-protein interactions,
by which Runx2 is recruited to sites without Runx2 binding motif, or
possible co-operative binding and/or collaboration of Runx2 with other
transcription factors at the same region. When comparing the top 20
enriched motifs in each sample, there were 9 common motifs found in
all samples (Table VII). Most of these were related to AP-1 family
proteins including Atf3, Fra1 and Jun-AP1 motif. These consensus
motifs are found at high frequency in the genome and are involved in a
wide variety of cellular processes.
Interestingly, another signiﬁcantly enriched motif in every data set
was for TEAD family factors and especially for TEAD4, present in
9–17% of Runx2 peaks in mouse and in 10% of peaks of human
samples. In Håkelien et al. original article, TEAD2 motif enrichment
was reported in regions enriched for promoter and enhancer related
histone modiﬁcations H3K4me3, H3K9ac and H3K27ac at the end of
diﬀerentiation, and its knockdown was then further shown to cause
impaired mineralization in vitro.
TEAD family of transcription factors are eﬀectors in the Hippo
signaling pathway regulating organ size by controlling cell proliferation
and apoptosis (Landin-Malt et al., 2016). TEADs form a complex with
Yes-associated protein (YAP) or its paralog transcriptional co-activator
with PDZ binding motif (TAZ) to activate target gene expression. Both
YAP and TAZ in turn interact also with Runx2 (Hong et al., 2005; Zaidi
et al., 2004) and they have been implicated in regulating MSC
diﬀerentiation (Hong et al., 2005) and in Wnt and BMP signaling
(Varelas, 2014). Very recently, stabilization of TAZ-Runx2 complex was
shown to play an important role in promoting osteoblastogenesis
(Matsumoto et al., 2016). When inspecting Runx2 peaks with the
Table IV
Genome-wide Runx2 peak distributions by the percentage of total peaks.
Meyer Wu Håkelien
D0_1 D0_2 D15_1 D15_2 D0 D9 D28 D28
3′UTR 0.6% 0.6% 0.6% 0.5% 0.5% 1.0% 0.8% 0.8%
TTS 1.4% 1.4% 1.0% 0.9% 1.5% 1.8% 1.5% 1.2%
Exon 2.2% 2.2% 0.8% 0.9% 3.4% 5.5% 4.3% 2.5%
Intron 36.5% 36.3% 32.9% 26.2% 30.7% 40.5% 36.2% 49.6%
Intergenic 38.1% 37.5% 52.2% 58.6% 32.0% 35.4% 33.1% 36.3%
Promoter 19.1% 19.9% 11.8% 12.1% 28.6% 13.3% 20.4% 8.0%
5′UTR 1.7% 1.9% 0.5% 0.7% 3.0% 2.3% 3.3% 1.1%
Other 0.3% 0.3% 0.3% 0.2% 0.3% 0.3% 0.4% 0.5%
Total 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Table V
Runx2 motifs enriched in HOMER motif enrichment analysis* of MC3T3-E1 cells.
Motif name Consensus sequence
RUNX2(Runt)/PCa-RUNX2-ChIP-Seq(GSE33889)/
Homer
A/T/C)TGTGGTT(A/T)
RUNX1(Runt)/Jurkat-RUNX1-ChIP-Seq(GSE29180)/
Homer
(G/T)(T/C)TGTGGTTT
RUNX(Runt)/HPC7-Runx1-ChIP-Seq(GSE22178)/
Homer
CTGTGGTTT(G/C)
*The analysis allowed for two mismatch nucleotides in the consensus sequence.
Table VI
Percentages of MACS peak sequences with Runx-related motifs detected by HOMER
analysis.
Peaks with RUNX motif
Sample Total number of
peaks
Peaks without
RUNX motif
Number Percentage
Meyer D0_1 26,297 16,792 9505 36.1
Meyer D0_2 22,962 14,304 8658 37.7
Meyer D15_1 9810 4514 5296 54.0
Meyer D15_2 34,871 20,813 14,058 40.3
Wu D0 14,396 9219 5177 36.0
Wu D9 53,887 31,310 22,577 41.9
Wu D28 32,894 20,088 12,806 38.9
Håkelien D28 80,061 68,603 11,458 14.3
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TEAD4 motif more closely, approximately half of the TEAD4 motif
containing peaks contained also Runx2 motif in mouse samples,
comprising 4–10% of all Runx2 peaks, whereas in human iMSCs only
1,5% of total Runx2 peaks contained both motifs (Supplemental Table
II). These results suggest that TEAD4 and Runx2 interaction might take
place at least in part of the Runx2 occupied regions through a common
protein complex (TEAD4 motif only regions) or through collaborative
binding via putative nearby DNA binding motifs (co-presence of TEAD4
and Runx2 motifs). Given the emerging literature of the importance of
TEAD/TAZ/YAP proteins in osteogenesis (Matsumoto et al., 2016; Tang
et al., 2016), role of TEAD-Runx2 interaction and protein complex in
osteoblasts would be highly interesting target for future studies.
3.2.6. Runx2 occupancy at the promoter regions
Runx2 binding sites where inspected in more detail at promoter
regions, which are more likely to be conserved across species than the
distal enhancer sites (Cheng et al., 2014). The promoter sequences (2 kb
upstream from TSS) of all orthologous pairs of human and mouse genes
were retrieved and annotated for the nearest ChIP-seq peaks in mouse
and human samples. The results of the extensive analysis are provided
in Supplemental Table III. The promoter coordinates, nearest peak
region's coordinates, and the distance of the peak from the promoter are
shown for all genes together with information indicating the number of
samples, in which Runx2 peaks were found. In addition, the number of
consensus Runx2 motifs found at each peak region is reported in the
table. If the peak distance from the promoter region is annotated as 0, it
means that the peak is overlapping with the promoter. Gene expression
data from the studies (described in detail in Section 3.3.) have been
integrated into the table as well. Another view of the data is presented
in Supplemental Table IV, which shows the presence of Runx2 at gene
promoters at diﬀerent time points together with the related gene
expression data, oﬀering possibility to assess the dynamics of Runx2
binding at individual gene promoters between the studies. These tables
with annotated gene information can be used as a resource, when
exploring possible Runx2 binding in the vicinity of any gene of interest.
For example, by ﬁltering and organizing columns in Tables SIII and SIV,
various groups of genes of interest can be selected based on their Runx2
binding properties and expression proﬁles.
We next searched for genes that had Runx2 peaks near the promoter
regions in all 7 mouse samples indicating high conﬁdence of constitu-
tive Runx2 binding during diﬀerentiation using the Supplemental Table
IV. These genes and their promoters had several common features. First,
most of these Runx2-occupied genes were relatively highly expressed
but only minority (11%) of them contained Runx2 motifs in the peak
regions. Similarly, the corresponding human orthologues of these genes
had nearby Runx2 peaks, were expressed and showed low frequency of
Runx2 consensus motifs. These observations suggest either Runx2 motif
is highly variant on these sites, or that Runx2 may be recruited to many
regions by other mechanisms than by direct binding to Runx2 motifs in
the DNA. Whether Runx2 binding is required for the transcription of
these genes is not clear. Interestingly, in the study of Wu et al. only 159
genes responded to Runx2 knockdown during diﬀerentiation, which is
far less than genes occupied by Runx2. As Runx2 has also genome-
organizing capabilities (Lian et al., 2003), it may well be that on these
other genes Runx2 modiﬁes the genomic landscape rather than directly
regulates gene expression.
Nevertheless, Wu et al. reported more Runx2 peaks in the shRunx2
downregulated genes (thus Runx2 upregulated genes) compared to
shRunx2 upregulated or nonresponsive genes. Accordingly, when we
inspected the abundance of Runx2 peaks and Runx2 motifs close to the
shRunx2 responsive/unresponsive genes (Table VIII), the shRunx2
downregulated genes contained indeed more Runx2 peaks per gene,
and especially more Runx2 motif containing peaks per gene (average
3,1/gene) than the upregulated or nonresponsive genes (average 1,1/
gene), supporting the high frequency of Runx2 motifs together with
Runx2 binding to be an strong indicator of direct transcriptional
activation by Runx2.
3.3. Gene expression data
The gene expression analysis was performed by using diﬀerent
platforms and experimental setups as described in Section 3.1., result-
ing in data provided in diﬀerent formats in on-line repositories. For the
comparisons, all gene expression data sets were processed to produce
normalized log2-transformed expression values for the expressed genes.
3.3.1. Diﬀerential gene expression analysis
Meyer et al. provided a ready-to-use table of gene expression
proﬁles obtained from mouse DNA microarray analysis of pre-osteo-
blast stage MC3T3-E1 cells (POB) and osteoblast stage MC3T3-E1 cells
(OB) after 15 days of diﬀerentiation. On the list, there were 721
transcripts including 498 signiﬁcantly diﬀerentially expressed genes
in the Meyer et al. study between the diﬀerentiation states. Wu et al. in
turn performed expression proﬁling at 0 and 9 days of diﬀerentiation of
MC3T3-E1 treated with either control scrambled shRNA or Runx2
targeting shRNAs leading to Runx2 downregulation. In the current
study, in order to compare gene expression proﬁles of MC3T3-E1 cells
Table VII
Top 20 enriched TF motifs in all Runx2 ChIP-seq samples.
Meyer Wu Håkelien
0 day 15 day 0 day 9 day 28 day 28 day
RUNX RUNX RUNX RUNX RUNX Atf3
RUNX1 RUNX1 RUNX1 RUNX1 RUNX1 BATF
RUNX2 RUNX2 RUNX2 RUNX2 RUNX2 Fra1
RUNX-AML RUNX-AML RUNX-AML RUNX-AML RUNX-AML AP-1
TEAD4 TEAD4 Fra1 Fra1 Fra1 Fosl2
TEAD TEAD BATF Atf3 BATF Jun-AP1
Fra1 TEAD2 Atf3 CTCF Atf3 Bach2
Fosl2 Atf3 Fosl2 BATF Fosl2 NF-E2
Jun-AP1 Fra1 Jun-AP1 Fosl2 AP-1 Bach1
BATF BATF AP-1 AP-1 Jun-AP1 Nrf2
TEAD2 AP-1 REST-NRSF Jun-AP1 CTCF MafK
Atf3 Fosl2 TEAD4 BORIS Bach2 ERG
AP-1 Jun-AP1 Bach2 Bach2 REST-NRSF ETV1
CTCF CTCF TEAD NF1 TEAD4 ETS1
Bach2 Ap4 TEAD2 TEAD4 TEAD TEAD4
NF1-halfsite BORIS Fli1 Klf4 Fli1 Fli1
BORIS Bach2 Elk4 KLF5 BORIS GABPA
Elk1 Atoh1 Elk1 EKLF TEAD2 TEAD
ETS Tcf12 ELF1 TEAD Ap4 MafA
Elk4 MyoG ETS Tlx Elk1 TEAD2
Table VIII
Number of Runx2 peaks and Runx2 consensus motifs at the Runx2 peaks at the promoter regions of shRunx2 responsive genes.
Average 200 bp region around peak center 500 bp region around peak center
shRunx2 response Gene count Annotated peaks Number of peaks/
gene
Peaks with Runx motif
(s)/gene
% of peaks with Runx
motif(s)
Peaks with Runx motif
(s)/gene
% of peaks with Runx
motif(s)
Down-regulated 44 288 6.5 3.1 47 4.3 65
Up-regulated 115 296 2.6 1.1 44 1.6 61
Non-responsive 20,788 58,886 2.8 1.1 40 1.6 57
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between Meyer and Wu studies, we analyzed only the data of control
shRNA expressing cells of Wu study and compared them to the parental
MC3T3-E1 cells used in Meyers study. Wu et al. provided normalized
signal values and probe IDs. Our analysis of diﬀerentially expressed
genes ﬁltered by adjusted p-value and the 2-fold change yielded 345
diﬀerentially expressed (DE) genes between the time points. For
Håkelien et al. study, raw RNA-seq read ﬁles of day 0 undiﬀerentiated
iMSC3 cells and day 28 diﬀerentiated iMSC3 cells were available and
were analyzed as described in materials and methods. The analysis
results were ﬁltered for adjusted p-value and the extent of diﬀerential
expression with 2-fold change. The ﬁltered gene list contained 3039
genes, 1504 up-regulated and 1535 down-regulated, the numbers being
in line with the 3157 diﬀerentially expressed genes reported in
Håkelien et al. study. Top ten diﬀerentially expressed genes in each
study are shown in Table IX. All DE gene lists are provided as
Supplemental Tables V–VII.
3.3.2. Heatmap of gene expression proﬁles
In order to compare gene expression proﬁles of all samples in Meyer
et al., Wu et al. and Håkelien et al. studies, the gene symbols in
Håkelien et al. data were translated to orthologous mouse gene
symbols. Log2-transformed expression values of all samples, scaled to
the same range and hierarchically clustered, are visualized in a heat
map in Fig. 3. The heat map clearly shows that samples coming from
the same study are most similar to each other based on their gene
expression proﬁles, regardless of the diﬀerentiation stage of the cells.
Thus, the eﬀects caused by diﬀerences in the cell clones or other
technical aspects between the studies mask the eﬀect of diﬀerentiation
on the overall gene expression proﬁles even in the samples from the
same species. The ﬁnding of only moderate changes in gene expression
proﬁles between the diﬀerentiation states might also reﬂect the fact
that MC3T3-E1 cells are already committed to the osteogenic lineage
and the most striking changes in gene expression from the stem cell
stage to preosteoblasts have already passed. Nevertheless, these results
demonstrate that the widely distributed cell lines may exhibit clonal
shift resulting in phenotypic/epigenetic/transcriptomic changes over
time, and highlight the importance of critical evaluation of results
obtained from a single cell line.
3.3.3. Similarity of gene expression proﬁles
In order to assess the similarity of the gene expression proﬁles
between the samples from diﬀerent studies using diﬀerent platforms
and even from diﬀerent species, R Bioconductor package OrderedList
(Yang et al., 2006) was utilized for detecting similarities of two ordered
gene lists. In short, two ranked lists (according to the mRNA expression
level) were compared and a similarity score was assigned based on the
number of overlapping genes in the top ranks. Plots of overlapping
genes in Meyer et al. and Wu et al. day 0 top or bottom ranked gene
expression lists are shown in Fig. 4A–B, where the overlap size increases
if the gene in top ranks of list 1 is found within the top ranks of list 2.
The observed overlap was compared to the expected overlap derived
from a hypergeometric distribution. The signiﬁcance of the similarity of
the lists within top 1000 genes was very high (Fig. 4B), with p-value of
0. Within top 100 genes the similarity was lower but still highly
signiﬁcant (Fig. 4A), with p-value 0,0026. Number of common genes in
these top 100 and top 1000 expressed gene lists was 15 and 271,
respectively. Similar comparisons for undiﬀerentiated human osteo-
Table IX
Top 10 signiﬁcantly diﬀerentially expressed genes in each study.
Meyer et al. 15d vs 0d Wu et al. 9d vs 0d shScramble Håkelien et al. 28d vs 0d
Gene name Log2FC Gene name Log2FC Gene name Log2FC
Cd200 6.233142 Lum 6.024314816 MMP13 11.50375
Mmp13 5.055013 Apod 4.675722274 COL10A1 10.72343
Itgbl1 4.405752 F13a1 3.826338637 DPT 10.20353
Lect1 4.374315 Ibsp 3.764573159 OMD 10.10910
Col15a1 4.164052 Mme 3.375728736 CHI3L1 9.27727
Igf2 4.03787 Omd 3.355162249 FAM20A 9.23509
Akap12 3.937885 Pgm5 3.349156029 BRINP1 9.21489
F13a1 3.900387 Ednra 3.213000637 SERPINF1 9.19554
Bmper −4.09268 Ppbp -3.205871844 GGT5 9.07341
Cxcl7 −4.58329 Anxa8 -3.106959652 MMP7 9.02634
Fig. 3. Heatmap of log2-transformed, normalized gene expression values of Håkelien
et al., Wu et al., and Meyer et al. samples. Dendrogram on top of the ﬁgure shows the
result of hierarchical clustering of the samples using Euclidian distances with complete
linkage method.
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blasts (Håkelien et al. day 0) and undiﬀerentiated mouse osteoblasts
(Meyer et al. day 0) and for diﬀerentiated human osteoblasts (Håkelien
et al. day 28) and diﬀerentiated mouse osteoblasts (Meyer et al. day 15)
are shown in Fig. 4C–F. In summary, all gene expression lists appeared
highly similar within the highly expressed, top-ranked genes. The
overlaps of the bottom ranked genes were close to random overlap,
which was expected as the genes at the bottom of the ranked lists are
mostly very lowly or not at all expressed and appear as random noise.
The similarity of the gene expression proﬁles was also evaluated
based on the pathway enrichment analysis of the gene expression
proﬁles. For the analysis, the gene expression lists of all samples
containing all the genes were ordered based on the log2 expression
values in descending order, and mouse gene symbols in Meyer et al. and
Wu et al. gene lists were translated to orthologous human gene symbols.
Fig. 5 shows Venn diagrams of the top 30 most signiﬁcantly enriched
pathways of all samples. The overlaps between the two mouse samples
are substantial, with 71% of the pathways in undiﬀerentiated Meyer
et al. and Wu et al. samples overlapping (Fig. 5A) and 58% of the
pathways in diﬀerentiated samples from the same studies overlapping
(Fig. 5B). The smaller overlap at the diﬀerentiated stage may be due to
diﬀerence in the time points, as in Meyer et al. cells have been
diﬀerentiated for 15 days but only 9 days in Wu et al. The comparisons
of human iMSC cells with MC3T3-E1 mouse cells show slightly less
overlap in the enriched pathways (Fig. 5C–F). Interestingly, for
undiﬀerentiated samples from Meyer et al. and Håkelien et al. samples,
the overlap is relatively high, 62%, suggesting the phenotype of the
cells to resemble each other closely although MC3T3-E1 represent
committed pre-osteoblasts and iMSCs multipotent stem cells. Compar-
ison of diﬀerentiated human osteoblasts to diﬀerentiated mouse
osteoblasts from Meyer's and Wu's studies show also a consistent
overlap of 58% in the 30 most signiﬁcantly enriched pathways in both
comparisons. However, when evaluating the similarity of gene expres-
sion proﬁles it is important to keep in mind that transcriptomes of
diﬀerent tissues consist of a large amount of ubiquitously expressed
genes. For example, in a RNA-seq analysis of multiple tissues, of the
11,000–13,000 expressed genes> 40% were shown to be expressed in
all tissue and cell types, and moreover that their mRNAs represented
75% of the total mRNA quantity expressed in any given cell type,
suggesting cell type speciﬁc mRNAs to account only the minority in a
mRNA pool (Ramsköld et al., 2009).
3.3.4. Correlation of Runx2 promoter occupancy and gene expression in
MC3T3-E1 cells
Mouse samples from Meyer et al. and Wu et al. studies were then
compared for Runx2 binding to promoter regions of genes that are
expressed at high or low levels in undiﬀerentiated and diﬀerentiated
cells. For this purpose, gene expression lists were ordered by decreasing
order of log2 expression level. We then analyzed Runx2 occupancy at
promoters (−2− 0 kb from TSS) of 20% of the highest and lowest
expressed genes at each time point. Bar graphs showing the number of
unique and common Runx2 occupied genes in the 20% highest/lowest
expressed gene groups between the timepoints in each study are shown
in Fig. 6. Consistently in both studies, Runx2 binding was remarkably
more abundant in promoters of highly expressed gene than of genes
Fig. 4. Comparison of gene expression data of A–B) Meyer et al. day 0 and Wu et al. day 0 samples, C–D) Håkelien et al. day 0 and Meyer et al. day 0 samples and E–F) Håkelien et al. day
28 and Meyer et al. day 15 samples using gene lists ranked by gene expression level in descending order. Overlap of top and bottom 100 and 1000 genes are shown for each comparison as
indicated in the ﬁgure. The overlap size is drawn as a step function over the respective ranks (black lines), with top ranks corresponding to the genes with highest expression and bottom
ranks to genes with lowest expression. The expected overlap and 95% conﬁdence intervals derived empirically from a hypergeometric distribution are shown in orange color. The
numbers of overlapping genes in the two lists are displayed as well as the permutation test p-values. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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with low expression. The pattern of Runx2 promoter peak distribution
was almost identical in undiﬀerentiated and diﬀerentiated cells, which
is in accordance with the observation that the gene expression proﬁles
were highly similar at the two diﬀerentiation stages in both studies.
Notable, more than half of the most highly expressed genes in both
Meyer et al. and Wu et al. studies contained Runx2 peaks at their
promoters, emphasizing that Runx2 has an important role in maintain-
ing the phenotype and gene expression proﬁle of osteoblastic cells.
Based on our analysis, the minor diﬀerence between the studies was
that there were very few unique Runx2 peaks in undiﬀerentiated cells
in Wu et al. study, while there was a signiﬁcant number of unique peaks
in day 0 sample in Meyer et al. study.
In Meyer's study close to half of the 721 DE transcripts between the
diﬀerentiation stages overlapped with Runx2 peak-associated genes
either at POB, OB or at both states. Similarly to our results, when they
looked at the 20% most highly or lowly expressed genes, they found the
most highly expressed genes in both POBs and OBs to be signiﬁcantly
more enriched with Runx2 peaks. In the original article of Wu et al. in
Fig. 5. Venn diagrams of the top 30 most signiﬁcantly enriched KEGG pathways in samples based on GSEA of ranked gene expression lists. A–B) The mouse osteoblast samples at both
diﬀerentiation stages from Meyer et al. and Wu et al. studies are compared. C–F) The human osteoblast samples from Håkelien et al. study are compared to mouse osteoblast samples from
Wu et al. and Meyer et al. studies at both diﬀerentiation stages. Percentage of overlapped pathways is displayed on the intersections.
Fig. 6. Distribution of Runx2 peaks on promoters of 20% highest/lowest expressed genes at diﬀerent time points in mouse MC3T3-E1 cells, A) in Meyer et al. and B) in Wu et al. study.
Yellow color indicates the proportion of peaks containing Runx2 motifs. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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turn reported 159 Runx2 responsive genes in a Runx2 shRNA knock-
down experiment of 9d diﬀerentiated cells. Most of these shRunx2
downregulated genes showed higher Runx2 enrichment close to the TSS
than the upregulated ones, which is in line with our observation that
the promoters of highly expressed genes are more occupied by Runx2
than the promoters of genes with low expression. Despite the abun-
dance of Runx2 at gene promoters of highly expressed genes, the
number of shRunx2 responsive genes seems to be surprisingly low,
suggesting other than direct transcriptional eﬀects of Runx2 binding at
most of the promoters. Accordingly, in SaOS osteosarcoma cells
abundant Runx2 occupancy at gene promoters was previously demon-
strated not to be directly correlated to gene expression nor highly
Runx2 occupied genes to be responsive to Runx2 depletion (van der
Deen et al., 2012). Interestingly, in our analysis, a consensus Runx2
binding motif was present only in a minority of the promoter areas
occupied by Runx2 (shown also in Supplemental Tables III and IV and
discussed in Section 3.2.6), further suggesting collaboration or co-
regulation with other proteins at these sites (Fig. 6).
4. Conclusions
We performed a small-scale meta-analysis of three published
osteoblast Runx2 ChIP-seq data sets of mouse and human origin and
in addition evaluated the similarity of their corresponding gene
transcription data produced by DNA microarrays or RNA-seq. From
the technical point of view, both ChIP-seq data and gene expression
data from two diﬀerent MC3T3-E1 clones showed high degree of
similarity, suggesting that overall ChIP-seq assay even in these diﬃcult
samples can produce reliable and reproducible data. Moreover, our data
demonstrates relatively small overall variation in the phenotypes of
these cells. By using similar data processing and analysis pipeline to all
data sets, we could conﬁrm some common features of Runx2 binding
reported in the original studies. First, while Runx2 binding is enriched
in the genic context including e.g. approximately 20% of all binding
sites at gene promoters, relatively high proportion of Runx2 peaks
remain in the intergenic genomic locations. Secondly, a substantial
portion of Runx2-occupied genomic regions do not contain consensus
Runx2 DNA binding motifs, suggesting the Runx2 motif to exhibit even
greater variability than previously shown, or that other DNA binding
mechanisms and/or collaborative binding with other protein complexes
may play an important role in determining Runx2 occupancy at speciﬁc
sites. Third, majority of the highly expressed genes in osteoblasts
contain bound Runx2 at their promoters, however the regulatory role
of Runx2 at these sites remain open. In addition, we evaluated inter-
species diﬀerences in Runx2 binding patterns in mouse and human
samples. In general, Runx2 binding features in the human sample
resembled closely the observations from mouse data. Importantly,
when mouse and human Runx2 binding at the vicinity of genes was
compared, approximately 40% of the genes showing highest enrich-
ment of Runx2 were in common, suggesting high degree of similarity
and thus conservation of Runx2 regulated mechanisms between the
species.
Regarding gene expression proﬁling, mouse MC3T3-E1 cells showed
similar gene expression proﬁles in two diﬀerent laboratories, but the
diﬀerentiation stage caused only minor changes in the global expression
proﬁle in these cells. Moreover, human iMSCs and mouse MC3T3-E1
gene expression proﬁles and enriched pathways showed substantial
similarity, suggesting these cell models to represent osteoblastic
phenotype in a similar manner. However, there were also some unique
cellular processes activated in each sample, highlighting the limitations
of in vitro models and importance of studying and reproducing
biologically relevant observations in more than one cell line. Finally,
our study demonstrates that objective re-analysis and pooling of
independent genome-wide NGS datasets is very important to validate
the ﬁndings of individual studies. With a higher number of replicates
and larger pool of data this type of analyses also allow for identiﬁcation
of the true target promoters/genes and pathways and mechanisms of
transcriptional regulation that might be otherwise missed.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gene.2017.05.028.
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